Jiuzhitang Co Ltd - Asset Resilience Ratio
Jiuzhitang Co Ltd (000989) has an Asset Resilience Ratio of 7.86% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiuzhitang Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Jiuzhitang Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Jiuzhitang Co Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Jiuzhitang Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 000989 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥450.51 Million | 7.86% |
| Total Liquid Assets | CN¥450.51 Million | 7.86% |
Asset Resilience Insights
- Limited Liquidity: Jiuzhitang Co Ltd maintains only 7.86% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Jiuzhitang Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiuzhitang Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
Annual Asset Resilience Ratio for Jiuzhitang Co Ltd (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Jiuzhitang Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.30% | CN¥505.41 Million ≈ $73.96 Million |
CN¥5.44 Billion ≈ $795.45 Million |
+3.54pp |
| 2024-12-31 | 5.76% | CN¥300.00 Million ≈ $43.90 Million |
CN¥5.21 Billion ≈ $762.60 Million |
+1.42pp |
| 2023-12-31 | 4.34% | CN¥231.20 Million ≈ $33.83 Million |
CN¥5.33 Billion ≈ $779.92 Million |
-1.60pp |
| 2020-12-31 | 5.94% | CN¥301.39 Million ≈ $44.10 Million |
CN¥5.07 Billion ≈ $742.12 Million |
-5.34pp |
| 2019-12-31 | 11.29% | CN¥553.58 Million ≈ $81.01 Million |
CN¥4.90 Billion ≈ $717.72 Million |
+7.87pp |
| 2018-12-31 | 3.41% | CN¥179.16 Million ≈ $26.22 Million |
CN¥5.25 Billion ≈ $767.94 Million |
+1.71pp |
| 2017-12-31 | 1.70% | CN¥100.00 Million ≈ $14.63 Million |
CN¥5.87 Billion ≈ $859.51 Million |
+1.64pp |
| 2010-12-31 | 0.06% | CN¥1.03 Million ≈ $150.35K |
CN¥1.74 Billion ≈ $254.40 Million |
0.00pp |
| 2009-12-31 | 0.06% | CN¥936.29K ≈ $137.01K |
CN¥1.55 Billion ≈ $226.45 Million |
-8.49pp |
| 2008-12-31 | 8.56% | CN¥132.28 Million ≈ $19.36 Million |
CN¥1.55 Billion ≈ $226.26 Million |
+7.85pp |
| 2007-12-31 | 0.70% | CN¥10.10 Million ≈ $1.48 Million |
CN¥1.44 Billion ≈ $210.96 Million |
-0.21pp |
| 2006-12-31 | 0.91% | CN¥12.56 Million ≈ $1.84 Million |
CN¥1.37 Billion ≈ $200.95 Million |
-5.04pp |
| 2005-12-31 | 5.95% | CN¥77.61 Million ≈ $11.36 Million |
CN¥1.30 Billion ≈ $190.72 Million |
+5.39pp |
| 2004-12-31 | 0.57% | CN¥7.61 Million ≈ $1.11 Million |
CN¥1.34 Billion ≈ $196.01 Million |
-0.29pp |
| 2003-12-31 | 0.86% | CN¥11.53 Million ≈ $1.69 Million |
CN¥1.34 Billion ≈ $195.70 Million |
+0.47pp |
| 2002-12-31 | 0.39% | CN¥3.95 Million ≈ $578.07K |
CN¥1.02 Billion ≈ $149.12 Million |
-- |
About Jiuzhitang Co Ltd
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong … Read more